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Abstract 
 
 Multidimensional fluorescent chemosensor data looking at the effect that rhodamine 
boronic acid dyes and fluorescein aldehyde dyes have on analytes of interest was 
collected by the Strongin Research Group. These sets of data have resulted in great 
qualitative results. A method to quantify the results, however, was desired. The major 
objective of this research was to reanalyze these sets of data using a new 
multidimensional analysis technique called Parallel Factor Analysis (PARAFAC) to 
obtain quantitative results. PARAFAC was performed on the data and new promising 
quantitative results were obtained. The promising results offered assertion of the use of 
PARAFAC on future studies of new multidimensional fluorescent chemosensor data.  
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1) Fluorescent Dyes and Analytes of Interest 
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The Strongin Research Group has done many studies on the effect of dyes on the 
fluorescent spectrum of a sample. Each study that was done on the dyes resulted in new 
information regarding ways to change the selectivity of the results by tweaking the 
conditions of the initial samples. It was found that multiple dyes have the ability to detect 
different classes of analytes. The dyes are all different colors, covering different regions 
of the spectra. A typical multidimensional fluorescence spectrum is an excitation 
emission matrix (EEM). An EEM can be thought of as a collection of a series of emission 
spectra over a wide range of excitation wavelengths. All of the excitation and emission 
spectra can be extracted from an EEM. If we slice at a particular excitation wavelength, 
such as 280nm, the slice we get will be an emission spectra excited at 280 nm. 
Conversely, if sliced the opposite way, at an emission wavelength at 280nm, it would 
result in an excitation spectra at this emission wavelength. Compared to only collecting a 
single pair of excitation and emission spectra, an EEM can provide more information 
because it covers all the wavelengths. EEMs make it easy to observe wavelength shifts 
and are ideal for a mixture of several components
1
. The fact that the dyes studied by the 
group are all different colors, they are able to cover all regions of the EEMs. Two dyes of 
interest in the Strongin Research Group are aldehyde-bearing fluorophores and 
rhodamine boronic acid (RhoBo).  
One type of dye that has been extensively studied by the research group is 
aldehyde-bearing fluorophores. Aldehyde-functionalized probes, such as fluorescein 
aldehyde, studied by Strongin et. al., are green and are used for the “optical detection of 
amino thiols,
2
” such as cysteine and homocysteine.  Three different fluorescein aldehydes 
have been studied to determine selectivity for thiols: fluorescein mono aldehyde, 
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dialdehyde, and an unsaturated aldehyde.  Both mono aldehyde and dialdehyde and their 
reaction to cysteine and homocysteine were studied in a sodium bicarbonate buffer, at a 
pH of 9.5. The reaction between mono aldehyde and dialdehyde with cysteine and 
homocysteine resulted in a yellow-to-orange color change and a shift in the absorbance 
maxima. Both mono and dialdehyde responded to the analytes, but dialdehyde had better 
selectivity. It was also found that there was a quenching-based response towards both 
analytes. The reason for this quenching response is photo induced electron transfer (PET) 
of the lone pair of electrons on the nitrogen
1
.  
In their paper, “Differences in heterocycle basicity distinguish homocysteine from 
cysteine using aldehyde-bearing fluorophores,” Strongin et al continued to look into 
fluorescein aldehydes reacting with cysteine and homocysteine.  This study investigated 
the reaction between the probe and analytes at low pH, rather than a high pH like 
previous studies had investigated. Low pH solutions resulted in PET inhibition, as 
hypothesized, resulting in fluorescent enhancement. Fluorescence of the probe was 
enhanced by homocysteine when the pH was changed from 5.5 to 6.0, but cysteine did 
very little to enhance the fluorescence. This difference in basicity between cysteine and 
the fluorescein aldehyde probe (pKa=.57) and homocysteine and the fluorescein aldehyde 
probe (pKa=6.7) allows for the selectivity of homocysteine over cysteine in basic 
solutions. 
Like the color change observed when cysteine and homocysteine reacted with 
mono and dialdehyde, the absorbance spectra of fluorescein aldehydes with other thiols 
also change color, as shown in Figure 1. Figure 1 shows the different colors of a 
fluorescein aldehyde probe with common t
and glutathione along with amino acids
 
  
 
 
Another dye that has been extensively studied is Rhodamine boronic acid (RhoBo). 
RhoBo is a unique boronic acid dye 
Most boronic acids preferentially respond to fructose and fructose derivatives. 
however, is unique because un
derivatives
5
.  The change of selectivity of RhoBo is due to
the dye and the sugars. RhoBo is 
a wavelength and time dependent 
dye. There are three rhodamine 
boronic dyes of interest, shown in 
Figure 2, one that is red, and two 
that absorb and emit at long-
wavelengths—one that emits and 
absorbs at a longer red 
wavelength and one that is near
IR
4
. 
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hiols such as L-methionine, mercaptoethanol, 
3,4
.  
that detects sugars and is used as a chemosensor. 
der certain conditions it is selective to ribose and ribose 
 binding interactions between 
-
 RhoBo, 
 One important study that the Strongin Research Group has used RhoBo in was that 
regarding the detection of adenylosuccinase deficiency (ADSL deficie
rare inborn error of purine metabolism that is contained within the broad autism spectrum. 
It is a very difficult disease to detect and is often underreported and misdiagnosed. It is 
are very high in concentration in ADSL deficient patients.
the substrates key to diagnosing ADSL deficient patients, neither of them 
commercially available. AICAr, also shown in Figure 3, is structurally similar to both S
Ado and SIACAr and is commercially available. It is for this reason that it is used as a 
model compound in studies related to ADSL
for ADSL deficiency because of its ability to react to ribose and ribose derivatives. 
AICAr is a ribose derivative. 
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ncy). ADSL is a 
for this reason that new ways of detecting 
ADSL are important.  
The substrates S-Ado and SAICar, shown 
in Figure 3, are a key to diagnosing ADSL.
Table 1 shows the concentrations of these two 
substrates and AICAr in urine in both healthy 
patients and those with ADSL deficiency.
you can see in the table, levels of both 
substrates are not present in healthy patients but 
 While S-Ado and SAIC
are 
6
.  RhoBo was key to studying hum
 
 
 As 
Ar are 
-
an urine 
In their experiment, highlighted in “Progress Towards Simple and Direct Detection 
of Adenylosuccinase Lyase Deficiency in Human Urine,” RhoBo was used in a 5 percent 
human urine mixture. AICAr was added via standard addition and the excitation emission 
spectra was recorded after each addition, shown in Figure 4 (a, b and c). This study 
showed that it was possibly to detect AICAr in human urine and that the concentration 
increased linearly when spiked
urine being a complex matrix containing lots of other sugars and potential interferences. 
However, there were still setbacks in the resulting data. Figure 
in a 5% urine mixture. There is a fair amount of signal, 
of fructose. Figure 4b shows the EEM upon t
a long wavelength peak that was not present in 
interferences making it hard to see the p
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 shown in Figure 4d. This result was promising due to 
4a is the EEM of RhoBo 
and the peak looks similar to that 
he addition of AICAr; as is apparent
4a, but still a large amount of background 
eak. To more clearly see this peak, the EEMs can 
be subtracted, giving 4c, in order to 
see the long wavelength peak. 
Although the intensity was shown 
to be linear as AICAr was added, 
subtracting the control can 
potentially hamper quantification. It 
was for this reason that a better way 
to remove interferences to quantify 
the data was desired
7
.  
, there is 
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 A second study done on RhoBo, highlighted 
in “Detecting specific saccharides via a single 
indicator,” looked at RhoBo in response to 
different analytes. RhoBo was first combined 
with AICAr and Fructose individually and EEMs 
of these two mixtures, along with a control EEM 
of just RhoBo, were recorded to demonstrate its 
response to different analytes, shown in Figure 5. 
As is evident from the EEMs, different analytes
different spectral regions allow a single indicator, 
such as RhoBo, to detect multiple analytes
 To show RhoBo’s dependence on time and 
wavelength using a single indicator, 
RhoBo with AICAr, fructose and mixtures of the 
two were scanned every 4 minutes for an hour.  
Taking EEMs over time allowed us to work with 
complex mixtures. The resulting EEMs, shown in 
Figure 6, show qualitatively that there are 
differences between each analyte. EEMs of the 
mixtures had characteristics of each analyte
the mixture that contained mostly AICAr resulted 
in an EEM looking more like the AICAr EEM 
and the mixture that contained mostly fructose 
 in 
8
.   
an EEM of 
, but 
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resulted in an EEM looking more like the fructose EEM. Though these visual differences 
were apparent, methods of quantitatively analyzing this data were desired. This study 
showed that a single indicator could be used to selectively qualitatively distinguish 
structurally related sugars simultaneously
7
. A powerful method to analyze 
multidimensional data is a method called Parallel Factor analysis (PARAFAC). Using 
this tool, the data from these studies could be analyzed and quantified. 
 Along with the desire for quantitative methods of analysis for these past studies, the 
idea of using a combination of both RhoBo and fluorescein aldehydes in future studies is 
of interest to the group. Combined with the autofluorescence of an analyte, both RhoBo 
and fluorescein aldehydes make it possible to measure the entire spectrum of EEMs. 
RhoBo covers from red to near-IR region of the spectra, fluorescein aldehydes cover the 
green range of the spectra and autofluorescence detects short wavelengths. Together, 
more of the spectra of each EEM could be covered, enabling better interpretation of data.  
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2) Multi-way Analysis 
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Multidimensional fluorescence as a metabonomic tool has many advantages. The 
method is very simple and has a rapid acquisition time. The method can analyze large 
sets of data and is very sensitive. Multidimensional data has been used before to detect 
diseases. Wavelength pairs and ratios, along with pattern recognition were used for this 
type of analysis in the past. Now chemometrics and PARAFAC are applied because they 
are believed to be a better method
9
. 
Parallel Factor Analysis (PARAFAC) is a very powerful multi-way decomposition 
method used in chemometrics. When there are multiple components in a sample, peaks of 
different components can overlap with each other, leading to more complex spectra. In 
order to know what each of the components are, the components need to be extracted into 
individual parts. PARAFAC can be used to extract the spectra of different components 
from the matrix. In, “PARAFAC. Tutorial and applications,” a paper by Bro, et al, the 
uses of PARAFAC are discussed. Bro, et al, created a Matlab toolbox, called the N-Way 
toolbox, which is an extension needed to complete PARAFAC. This paper discusses the 
different analysis that the toolbox can do to analyze the data collected in the fluorometer
3
. 
To use PARAFAC, Excitation Emission Spectrums (EEMs) are first collected. These 
EEMs are then combined to make a three dimensional matrix. PARAFAC is then run, 
decomposing this data into its distinct components. PARAFAC shows different analytes 
in mixtures and can give information on their concentrations and spectra
1
.   
In hopes to find a method to quantitatively analyze data collected, the data from the 
previous studies mentioned above was reanalyzed using PARAFAC.  
 
11 
 
 
 
 
 
 
 
3) Reanalysis Using Multi-Way Analysis 
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  The data collected in the afore mentioned studies involving RhoBo and 
fluorescein aldehyde dyes accounted for multiple dimensions, but were not looked at as 
such. The results of these studies gave good qualitative analysis of the data, but methods 
to quantify the data were desired. With PARAFAC, these multiple dimensions could be 
taken into account and quantitative analysis could be done. 
The data shown above in Figure 6 is one set of data that was analyzed with PARAFAC. 
When PARAFAC was performed, each EEM was decomposed into a weighted sum of 
two species, a short and long wavelength. Each of these two species had an emission and 
excitation peak, shown in Figure 7. Figure 7a shows the short wavelength component and 
Figure 7b shows the long wavelength component. It was observed in previous studies that 
the optimum wavelength for quantification of AICAr was at a long wavelength spectrum, 
13 
 
similar to the long wavelength component shown in Figure 7(a). Similarly, the optimum 
wavelength for quantification of interference spectra in past studies was found to be at a 
short wavelength spectrum, similar to the short wavelength component shown in Figure 
7(b).  
PARAFAC was used to extract the data into its separate components and these 
components change over time. The magnitude of each component and how they changed 
over time was then graphed for AICAr and fructose, shown in Figure 8. These plots show 
the score, which corresponds to the concentration of each component, as they change 
over time. The manner in which each component changes over time, along with the 
magnitudes for each, varies from analyte to analyte. AICAr (Figure 8(a)) has a long 
wavelength component that steadily increases, plateaus at about 30 minutes and then 
decreases. The short wavelength component stays relatively constant. Fructose (Figure 
8(b)) has a long wavelength component that starts high and decreases over time, while 
the short wavelength component starts low and increases. Qualitatively, these two data 
sets appear very different. One way to show these differences in a quantitative method 
was to plot the ratio of the two as they change over time, so this was done for each; the 
plot of the ratio is shown in black in both graphs in Figure 8.  The ratio of AICAr was 
clearly different than the ratio for fructose.  
To further see how the ratio changes as the AICAr and fructose mixture changes, the 
mixtures were investigated at one point in time. Figure 9 shows the EEMs that were 
looked at to determine this ratio, which corresponds to the fourth row of EEMs in Figure 
6, recorded after about 15 minutes. Qualitatively, it was evident that the EEM for AICAR 
is different than that of fructose. Features of both can be seen in the three mixtures, 
of the ability to quantitatively analyze similar data in the future. 
The second study with RhoBo
Adenylosuccinase Lyase Deficiency in Human Urine,” 
human urine. Complex matrices such as this often have large interferences.
remove interferences in complex matrices was desired. PARAFAC provided a route to do 
that. As shown again in Figure 11(a
14 
 
though those that are AICAr heavy have
features dominated by long wavelength 
peak, like AICAr and those mixtures that 
are heavy in fructose are dominated by 
short wavelength, similar to fructose
ratio plotted as a function of AICAr 
concentration in the mixture was then 
plotted, Figure 10.  Plotted as a function 
of AICAr concentration, the ratio 
generally increased with increasing AICAr. 
This result was promising and indicative 
 
 in “Progress Towards Simple and Direct Detection of 
dealt with a more complex 
 A way to 
-c), the EEMs in presence of urine have larg
 
. The 
matrix, 
e short 
15 
 
wavelength interference. PARAFAC completely resolved the background peak and 
isolated it the two components of the sample, leaving the peak of interest to be analyzed. 
The short wavelength species did not change upon spiking with AICAr, but the long 
wavelength species increased linearly as expected (Figure 12). When PARAFAC was run, 
the interference was eliminated, saving time and leaving less room for the data to be 
hampered with. Though PARAFAC resolved the background peak there was still an 
indicator background present, which needs to be minimized before any standard addition 
procedures are done. 
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4) Future Work 
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One short-term goal for future research is to analyze global data sets instead of at 
just one time point for data collected over a longer period of time. It is hypothesized that 
analysis of global data sets would further improve quantitative analysis.   
Lawaetz, et al, first introduced the idea of using multi-way analysis for 
metabonomic diagnostics. Metabonomic diagnostics is based on non-targeted 
measurements of metabolites in biological systems usually using nuclear magnetic 
spectroscopy (NMR), liquid chromatography (LC) and gas chromatography (GC) 
combined with mass spectroscopy (MS).
10,11
 In their paper, "Fluorescence Spectroscopy 
as a Potential Metabonomic Tool for Early Detection of Colorectal Cancer," they used a 
PARAFAC, to try to detect Colorectal Cancer.  
The main purpose of the paper was to discuss the use of fluorescent spectroscopy 
as a tool for the detection of colorectal cancer and how this technique could be used as a 
metabonomic tool. The study used two different control groups, healthy patients (or 
patients with non-malignant findings) and patients with colorectal cancer. Excitation 
Emission Spectrum (EEM) were collected on their plasma and were then analyzed using 
PARAFAC to look for differences in the chemical components. This method showed 
shifts in the Tryptophan emission of cancer patients, which confirmed previous findings 
by other methods; the method also showed much clearer results.
12
 The paper proved that 
this method of analysis could be used to detect chemical changes correlated with a 
disease, which is why we hypothesize that this same method could be used for the 
detection and diagnoses of sepsis.  
18 
 
Sepsis is a serious bloodstream infection that can rapidly become life-threatening. 
A clinical syndrome, sepsis is defined by the presence of both system inflammatory 
response and infection in the body that can arise from various infections, such as those 
“from the skin, lungs abdomen, and urinary tract
13,14
.” In the United States alone, over 
1.1 million people are affected yearly by sepsis. On average, 36 people die per hour 
because of the disease
8
. Despite medical advancements, sepsis is slowly becoming more 
common in patients
15
 and though they are treated with high expenditures, sepsis is more 
often than not, fatal. Though not all have fatal encounters with sepsis, people who survive 
are likely to live with organ damage, cognitive impairment and physical disabilities
8
.   
Historically, sepsis has been diagnosed via a broad set of symptoms including 
abnormalities in body temperature, heart rate, respiratory rate, and white blood cell count. 
When two or more symptoms of systematic inflammatory response syndrome (SIRS) are 
present, infection is considered to be sepsis. Symptoms of the systematic inflammatory 
response syndrome include: ‘body temperature higher than 38°C or lower than 36°C; 
heart rate higher than 90/min or more than two SD above the normal value for age; 
tachypnea; alterations in the white blood count, and the presence of more than 10 percent 
immature neutrophils’. More severe forms of sepsis include sepsis in association with 
organ dysfunction, hypoperfusion and hypotension. Septic shock is sepsis with arterial 
hypotention
7
. 
Sepsis detection is often delayed because of the non-specific symptoms and the 
time-consuming lab techniques. The time that it takes for diagnostics is very important 
however because there is a 7.6% increase in mortality for every hour that a patient 
remains undiagnosed or untreated
16
. Currently, the main clinical method for diagnosis of 
19 
 
sepsis is blood testing. This method of diagnosis is very time consuming. Early detection 
of sepsis is key in lowering the rate of mortality
17
, making blood testing very inefficient. 
Blood testing is difficult and less effective for neonates because they do not have the 
amount of blood needed and they are often asymptomatic until respiratory collapse is a 
danger. The amount of blood required for testing is two samples of 20-30 ml
11
. Because 
of this, neonates are often treated with antibiotics that can cause major side effects, such 
as deafness and renal failure in newborns that are misdiagnosed with sepsis
18
.  
As stated above, blood testing is very time-consuming. The incubation period 
takes at least 8 hours and can take upwards of 96 hours
19
.  Culture reports are then ready 
in 24-48 hours
11
. Cultures come out negative almost 50% of the time when severe sepsis 
is sampled after antibiotics administration
20
. It is for this reason that new methods of 
detection are beginning to be investigated.  
Now that new methods of analysis, such as PARAFAC, have been explored, the 
future goal of the research project is to apply this fluorescent-based metabonomic 
approach to early diagnoses of sepsis. There are several biomarkers in blood that 
autofluoresce, which would allow healthy patients to be distinguished from those with 
disease. If the autofluorescence is combined with a rhodamine boronic acid dye, a 
fluorescein aldehyde dye, or a combination thereof and PARAFAC, it is predicted that 
the potential to detect shifts in the chemical composition of known biomarkers would 
increase.  
The process of this future research has many aspects to it, making this a long-term 
goal for the group. In order to determine any trends, hundreds of samples will be needed 
20 
 
for analysis. Due to the samples being plasma samples from sick and healthy patients, the 
institutional review board will have to approve of the research and many clinical studies 
will need to be completed.  
21 
 
 
 
 
 
 
 
 
 
 
 
 
5) Concluding Remarks 
22 
 
 
Much research has been done on the effect that rhodamine boronic acid (RhoBo) 
and fluorescein aldehyde have on fluorescent spectra of analytes. Both dyes can be tuned 
in order to detect analytes of interest. RhoBo is wavelength and time dependent and is 
selective towards ribose and ribose derivatives. Fluorescein aldehyde is selective towards 
thiols.   
Parallel Factor analysis (PARAFAC) provides a multi-dimensional way to 
analyze EEM’s and decompose them into their components. Decomposing EEMs 
provides a better way to quantitatively analyze large sets of data, thus improving results. 
Work is ongoing to improve the results of PARAFAC analysis, including tailoring future 
experiments to assure proper data collection. Analysis of more global data sets is also 
ongoing, as it is hypothesized that these larger sets of data will further improve 
quantitative analysis of data collected.  
A long-term goal of the research group is to use RhoBo and fluorescein aldehyde, 
along with PARAFAC to detect and diagnose sepsis. Doing so would provide a faster, 
more efficient way of diagnosing.  
23 
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